DNER and hepatocellular carcinoma: Here, we conducted a genome-wide analysis of the transcript changes potentially underlying by treating the human HCC cell lines HepG2 and Huh7 with the BET inhibitors JQ1, OTX015, or ABBV-075 the inhibition of HCC progression.